The drug regulator’s recent suspension of Sun Pharmaceutical Industries’ clinical research activities at its Mumbai-based bio-analytical laboratory has raised concerns among other companies doing similar research and development work. The pharmaceutical industry is particularly worried that following the recent directives from the Supreme Court, the regulator may turn more stringent, impacting ongoing projects and future clearances. While the regulator has suspended Sun Pharma’s Mumbai laboratory citing absence of approval for the site, the firm maintains it has ...
Regulator's moves worry pharma sector
Pharmaceutical industry is particularly worried that following the recent directives from the Supreme Court
BS Reporter |